Не сдохни! Еда в борьбе за жизнь

^{‹‹53››.} Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson’s disease. Mov Disord. 2012;27(8):947–57.

^{‹‹54››.} Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.

^{‹‹55››.} Brody AL, Mandelkern MA, London ED, et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006;63(8):907–15.

^{‹‹56››.} Searles Nielsen S, Gallagher LG, Lundin JI, et al. Environmental tobacco smoke and Parkinson’s disease. Mov Disord. 2012;27(2):293–6.

^{‹‹57››.} Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113–20.

^{‹‹58››.} Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.

^{‹‹59››.} Nielsen SS, Franklin GM, Longstreth WT, Swanson PD, Checkoway H. Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol. 2013;74(3):472–7.

^{‹‹60››.} Richardson JR, Shalat SL, Buckley B, et al. Elevated serum pesticide levels and risk of Parkinson disease. Arch Neurol. 2009;66(7):870–5.

^{‹‹61››.} Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson’s disease. J Toxicol Environ Health Part A. 2000;59(4):229–34.

^{‹‹62››.} Hatcher-Martin JM, Gearing M, Steenland K, Levey AI, Miller GW, Pennell KD. Association between polychlorinated biphenyls and Parkinson’s disease neuropathology. Neurotoxicology. 2012; 33(5):1298–304.

^{‹‹63››.} Kanthasamy AG, Kitazawa M, Kanthasamy A, Anantharam V. Dieldrin-induced neurotoxicity: relevance to Parkinson’s disease pathogenesis. Neurotoxicology. 2005;26(4):701–19.

^{‹‹64››.} Arguin H, Sanchez M, Bray GA, et al. Impact of adopting a vegan diet or an olestra supplementation on plasma organochlorine concentrations: results from two pilot studies. Br J Nutr. 2010; 103(10):1433–41.

^{‹‹65››.} Jiang W, Ju C, Jiang H, Zhang D. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.

^{‹‹66››.} Park M, Ross GW, Petrovitch H, et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology. 2005;64(6):1047–51.

^{‹‹67››.} Kotake Y, Yoshida M, Ogawa M, Tasaki Y, Hirobe M, Ohta S. Chronic administration of 1-benzyl- 1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate. Neurosci Lett. 1996;217(1):69–71.

^{‹‹68››.} Niwa T, Yoshizumi H, Takeda N, Tatematsu A, Matsuura S, Nagatsu T. Detection of tetrahy- droisoquinoline, a parkinsonism-related compound, in parkinsonian brains and foods by gas chromatography- mass spectrometry. Advances in Behavioral Biology. 1990;38A:313–6.

^{‹‹69››.} Niwa T, Yoshizumi H, Tatematsu A, Matsuura S, Nagatsu T. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods. J Chromatogr. 1989;493(2):347–52.

^{‹‹70››.} Niwa T, Takeda N, Kaneda N, Hashizume Y, Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains. Biochem Biophys Res Commun. 1987;144(2):1084–9.

^{‹‹71››.} Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.

^{‹‹72››.} Ułamek-Kozioł M, Bogucka-Kocka A, Kocki J, Pluta R. Good and bad sides of diet in Parkinson’s disease. Nutrition. 2013;29(2):474–5.